Financial Disclosure Ernst Lengyel disclosed that money was paid to his institution from
AbbVie (funding preclinical studies), NCI (RO1 grants), and the Ovarian Cancer Research …

Epithelial ovarian cancer is the second commonest cause of death amongst all
gynaecological cancers. Treatment is challenging because almost 75% of cases are …

Ovarian carcinoma is characterized by heterogeneity at the molecular, cellular and
anatomical levels, both spatially and temporally. This heterogeneity affects response to …

Background Effective tumor debulking is a major factor associated with a favorable
prognosis in patients with advanced ovarian cancer (AOC). However, FIGO staging fails to …

Simple Summary Epithelial ovarian cancer is one of the most lethal cancers in women and is
typically diagnosed at an advanced-stage. Historically, primary tumor reductive surgery was …

Simple Summary Maximal-effort debulking surgery is the recommended approach for
advanced-stage ovarian cancer. The role of imaging is to provide a preoperative systematic …

(1) The degree of cytoreduction achieved during primary debulking surgery (PDS) is an
important prognostic factor for the survival of patients with epithelial ovarian cancer (EOC) …

OBJECTIVE: To estimate the effects of a laparoscopic scoring algorithm to triage patients
with advanced ovarian cancer to immediate or delayed debulking to improve complete gross …

Objective This study aimed to explore the value of a radiomics nomogram to identify
platinum resistance and predict the progression-free survival (PFS) of patients with …

The standard treatment for advanced ovarian cancer (AOC) is cytoreduction surgery and
adjuvant chemotherapy. Tumor volume after surgery is a major prognostic factor for these …